Cleared Traditional

K230540 - Patient Specific Planning Solution 3D B...

K230540 is the FDA 510(k) clearance for Patient Specific Planning Solution 3D B... by Biomet Manufacturing Corp. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 148-day FDA review.

K230540 · Biomet Manufacturing Corp · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
148d
Days
Class 2
Risk

K230540 is an FDA 510(k) clearance for the Patient Specific Planning Solution™ 3D Bone Models. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Biomet Manufacturing Corp (Warsaw, US). The FDA issued a Cleared decision on July 25, 2023 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Biomet Manufacturing Corp devices

Submission Details

510(k) Number K230540 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2023
Decision Date July 25, 2023
Days to Decision 148 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 107d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1091
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K230540.
CUPTIMIZE™ Advanced
K231503 · DePuy Orthopaedics, Inc. · Aug 2023
SaintView
K223660 · Inviz Corporation · Aug 2023
Efai Pacs Picture Archiving and Communication System Pro
K232100 · Ever Fortune.Ai, Co., Ltd. · Aug 2023
Argus Cognitive ReVISION Software
K223322 · Argus Cognitive, Inc. · Jul 2023
Fibroid Mapping Reviewer Application (FMRA)
K222683 · Nesa Medtech Private Limited · Jul 2023
CommandEP Data Manager PC (DPC02), CommandEP HMD (HMD02)
K223290 · Sentiar, Inc. · Jul 2023